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DAHPSa b s t r a c t
3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS) catalyses the ﬁrst step of the shi-
kimate pathway for the biosynthesis of aromatic amino acids. Allosteric regulation of Thermotoga
maritima DAH7PS is mediated by L-Tyr binding to a discrete ACT regulatory domain appended to
a core catalytic (b/a)8 barrel. Variants of T. maritima DAH7PS (TmaDAH7PS) were created to probe
the role of key residues in inhibitor selection. Substitution Ser31Gly severely reduced inhibition
by L-Tyr. In contrast both L-Tyr and L-Phe inhibited the TmaHis29Ala variant, while the variant where
Ser31 and His29 were interchanged (His29Ser/Ser31His), was inhibited to a greater extent by L-Phe
than L-Tyr. These studies highlight the role and importance of His29 and Ser31 for determining both
inhibitory ligand selectivity and the potency of allosteric response by TmaDAH7PS.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Aromatic metabolites are biosynthesised in plants and microor-
ganisms by way of the shikimate pathway [1]. This pathway com-
prises a series of seven enzyme-catalysed reactions resulting in
the formation of chorismate. Chorismate is the precursor of many
important aromatic metabolites including the folates, quinones
and the aromatic amino acids, L-Phe, L-Tyr and L-Trp. The enzyme,
3-deoxy-D-arabino-heptulosonate 7-phosphate synthase (DAH7PS),
catalyses the ﬁrst committed step of the pathway. The regulation of
entry into the pathway by controlling the catalytic activity of
DAH7PS is an important mechanism for determining cellular levels
of the aromatic amino acids (Fig. 1).
One of the striking differences between DAH7PSs from different
sources is the variation in allosteric mechanisms and associated
allosteric machinery [2]. Whereas all known DAH7PS proteins
share the same core catalytic (b/a)8 barrel, this barrel is appended
with different extensions for the purpose of allosteric control by
pathway intermediates or by the aromatic amino acids. Type Iaenzymes from Escherichia coli, Saccharomyces cerevisiae, and Neisse-
ria meningitidis have N-terminal and loop extensions that create a
single ligand binding site for one of the aromatic amino acids [3–6].
The type II enzyme from Mycobacterium tuberculosis has three li-
gand binding sites, which operate synergistically to provide an
allosteric response [7–9]. The recently structurally characterised
type Ib DAH7PS from Listeria monocytogenes has a fused chorismate
mutase domain, which is thought to provide a binding site for the
regulation of DAH7PS activity by chorismate or prephenate [10]. In
contrast to these examples, for which the allosteric ligand binding
site is pre-formed by peptide or domain insertions to the barrel,
allosteric inhibition of the type Ib DAH7PS from Thermotoga mari-
tima (TmaDAH7PS) is mediated by a discrete N-terminal ACT-like
domain [11–13].
The ACT domain, named after the ﬁrst three proteins in which
the domain was recognised (aspartate kinase, chorismate mutase
and TyrA), is a babbab structural motif involved in the regulation
of amino acid metabolism [14–16]. TmaDAH7PS is allosterically
inhibited by L-Tyr, and while L-Phe does inhibit the enzyme, it is
considerably less potent an inhibitor [13]. The structural and
functional characterisation of a truncated variant lacking the N-
terminal ACT domain, and a L-Tyr-bound structure of TmaDAH7PS
have shown that this domain is essential for allosteric regulation
[12]. A signiﬁcant change in the average conformation of the
protein is observed upon ligand binding whereby L-Tyr is bound
in a cleft formed between two diagonally opposing N-terminal
ACT domains of the tetrameric protein, and contributions from
Fig. 1. The shikimate pathway detailing the ﬁrst reaction, which is catalysed by DAH7PS. The pathway branches at chorismate to form a number of important aromatic and
pre-aromatic products.
Fig. 2. (A) Comparison of the position of the regulatory ACT domain of TmaDAH7PS
in the unbound (blue) and L-Tyr-bound (green) conformations. (B) The L-Tyr (yellow
sticks) binding site with residues contributed from ACT domains from opposing
monomers represented as either magenta or green sticks. Hydrogen bonding
interactions are shown by black dashes.
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directly to the interactions with L-Tyr (Fig. 2). Placement of the
regulatory domains in this way physically blocks substrate entry
into the active site and alters the conformation of the active site
loops, impeding the catalytic activity of the enzyme.
Herein we describe the characterisation of three variants of
TmaDAH7PS in which substitutions were made to key residues of
the ACT-like domain located in the Tyr-binding site. These studies
demonstrate the importance of these residues in both the selectiv-
ity for L-Tyr as allosteric effector of this enzyme, and for controlling
the sensitivity of the enzyme towards inhibitors.
2. Materials and methods
2.1. Bacterial strains, plasmids, media, growth conditions
Site directed mutagenesis was performed using the Quik-
Change Lightning site-directed mutagenesis kit (Stratagene),
and pT7-7 TmaDAH7PS as the double stranded plasmid template
to create the His29Ala (TmaH29A), Ser31Gly (TmaS31G) and His29-
Ser/Ser31His (TmaH29S/S31H) variations of TmaDAH7PS. Muta-
genic primers TmaDH29AFor 50-GAGAGTTACAACTTGAAGTGTGCC
ATTTCCAAAGGTCAGGAAAG and TmaDH29ARev 50-CTTTCCTGACCT
TTGGAAATGGCACACTTCAAGTTGTAACTCTC were used to convert
histidine to alanine, TmaDS31GFor 5’-ACAACTTGAAGTGTCACATTG
GCAAAGGTCAGGAAAGAACGG and TmaDS31GRev 50-CCGTTCTT
TCCTGACCTTTGCCAAAGGTCAGGAAAGAACGG for serine to glycine
conversion and TmaDH29S/S31HFor 50-GGCCGAGAGTTACAACTT-
GAAGTGTAGCATTCACAAAGGTCAGGAAAGAACGGTTATT andTmaDH29S/S31HRev 50-AATAACCGTTCTTTCCTGACCTTTGTGAATGC
TACACTTCAAGTTGTAACTCTCGGCC (mutations shown in bold) to
interchange the serine and histidine residues. The sequences of
the variants were veriﬁed, after which the vectors were trans-
formed into E. coli (DE3) Star cells. Cultures were grown, overex-
pressed and puriﬁed as previously described for wild type
TmaDAH7PS [12].
2.2. Determination of molecular mass
The masses of the puriﬁed proteins (diluted to 1 mg ml1 using
milliQ water) were measured by electrospray ionisation using a
Bruker maXis™ 3G (Bruker Daltonics).
2.3. Michaelis Menten kinetics
Enzyme activity was monitored and kinetic parameters deter-
mined as previously described [12]. Assays used to determine the
kinetic parameters of all variants of TmaDAH7PS contained
100 lM MnSO4, 2 ll of 0.5–1.2 mg ml1 enzyme in 50 mM BTP,
pH 7.3 buffer. To determine the KE4Pm , the PEP concentration was
ﬁxed at 80 lM (except for TmaH29S/S31H for which PEP was ﬁxed
at 200 lM), while the E4P concentration was varied (11–220 lM).
For determination KPEPm , E4P concentration was ﬁxed at 160 lM
while the PEP concentration was varied (10–200 lM).
2.4. Response to inhibitors
The assay mixtures to determine the effect of L-Tyr and L-Phe on
the activity of the variants contained PEP (120–200 lM, 5–9  Km),
E4P (200–220 lM, 7–8  Km) and MnSO4 (100 lM) in 50 mM BTP,
pH 7.3. Reaction mixtures have either no amino acids or 0–1 mM
L-Tyr or L-Phe. Triplicate assays were performed for all reaction
conditions.
2.5. Small angle X-ray (SAXS) scattering data collection
Measurements were performed at the Australian Synchrotron
SAXS/WAXS beamline with a Pilatus detector (1 M,
170  170 mm effective pixel size, 172  172 lm). The wavelength
of the X-rays was 1.0332 Å. The sample detector distance was
1576 mm, which provided a q range of 0.0126–0.400 Å1 (where
q is the magnitude of the scattering vector, which is related to the
scattering angle (2h) and the wavelength (k) as follows: q = (4p/
k)sinh. Data were collected from a 1.5 mm glass capillary at 27 C
at 2 s intervals. Scattering datawere collected from the TmaDAH7PS
variants (2 mg ml1) with or without L-Phe or L-Tyr (1 mM).
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ized to sample transmission and background-subtracted.
2.6. SAXS data analysis
Scattered intensity (I) was plotted versus q. Extrapolation of the
DAH7PS I(q) proﬁles to zero angle (I(0)) and comparison with glu-
cose isomerase standards indicated a molecular mass consistent
with the TmaDAH7PS tetramer. All samples were devoid of an
increase in intensity at low q (indicative of aggregation). Guinier
plots were linear for qRg < 1.3. The data sets for structural analyses
were recorded with 294 data points over the range
0.01 6 q 6 0.4 Å1. Indirect Fourier transform was performed using
GNOM [17] to yield the P(r) function, which gives both the relative
probabilities of distances between scattering centres and the max-
imum dimension of the scattering particle Dmax. Theoretical scat-
tering curves were generated from atomic coordinates and
compared with experimental scattering curves using CRYSOL [18].
3. Results
3.1. Mutations in the regulatory domain result in catalytically active
variants of TmaDAH7PS
Three residue substitutions were chosen on the basis of the
interaction of their side-chains with L-Tyr and by analogy with
the studies of the type Ia DAH7PS subfamily, in which ligand spec-
iﬁcity appears to be determined primarily by a single residue [5].
Unlike the L-Tyr-sensitive type Ia enzymes, which have a Gly res-
idue at the bottom of the preformed ligand binding cavity in close
proximity to the L-Tyr hydroxyl group [5], TmaDAH7PS has a Ser
residue (Ser31) in this position. In contrast, Ser is found in an anal-
ogous position for the Phe-sensitive type Ia enzymes [3]. One of
the notable interactions of the Tyr-bound form of TmaDAH7PS is
a hydrogen bond between the hydroxyl group of the L-Tyr ligand
and the side chain of Ser31 (Fig. 1B). Ser31 of TmaDAH7PS was
changed to Gly to remove this interaction with the hydroxyl moi-
ety of L-Tyr and to eliminate the hydrogen bond to His29 on the
opposing subunit.
His29, contributed by the opposing ACT domain, hydrogen
bonds to the hydroxyl group of Ser31 and although not directly in-
volved in binding directly to the inhibitor, could function in secur-
ing the correct orientation of either Ser31 or the Tyr ligand. His29
was substituted for Ala in order to evaluate the signiﬁcance of this
role by His29 in TmaDAH7PS.
To assess the importance of the hydrogen-bonding contacts be-
tween the two domains, mediated by His29 and Ser31, these resi-
dues were also interchanged, by construction of the His29Ser and
Ser31His double variant. Conformers are possible for this variant
which maintain an intermolecular hydrogen bond between the ex-
changed His and Ser residues, yet are unlikely to support the
hydrogen bond to Tyr.
The three variant proteins were expressed and puriﬁed. The
molecular weights of the variant proteins were determined by
mass spectral analysis and were in agreement with the expected
molecular weights calculated from the sequences. All three vari-
ants were catalytically active and despite the distance of the aminoTable 1
Kinetic parameters of the reaction catalysed by wild-type TmaDAH7PS and variants. The k
TmaDAH7PS KPEPm (lM) K
E4P
m (lM) kc
Wild type 4.85 ± 0.04 13 ± 1 11
H29A 12.8 ± 0.4 30 ± 1 17
S31G 21 + 2 33 ± 2 14
H29S/S31H 39 ± 1 28 ± 1 14acid substitutions from the active site, the variants all displayed al-
tered catalytic properties (Table 1). All variants were found to have
higher Michaelis constants for both substrates in comparison to
the wild type TmaDAH7PS. On the other hand, the turnover num-
ber kcat, was slightly higher for all of the variants.
3.2. Small angle X-ray scattering reveals conformational change on L-
Tyr and L-Phe binding
In the presence of L-Tyr, the observed average conformation of
TmaDAH7PS is altered, and this can be detected by changes in
the small angle X-ray scattering (SAXS) proﬁle. SAXS experiments
were used to investigate whether this change conformational in
the average conformation was also apparent for the variant en-
zymes. Data were collected for each protein in the absence and
presence of L-Phe and L-Tyr and the scattering proﬁles were com-
pared to the response of wild type TmaDAH7PS (Fig. 3).
The scattering proﬁles of all proteins were very similar in the
absence of ligand or in the presence of 1 mM L-Phe or 1 mM
L-Tyr, indicating that, in solution, the proteins adopt on average
the same overall fold and tetrameric quaternary structure as the
wild type enzyme. This correspondence is further veriﬁed by the
similarity of the pair distribution functions (P(r)), calculated using
the indirect Fourier transformation and the radius of gyrations (Rg,
as determined by Guinier analysis) between the variants and wild
type TmaDAH7PS (Table S1, Supplementary information).
On addition of L-Tyr or L-Phe, signiﬁcant changes to the scatter-
ing proﬁles were observed in all cases (Fig. 3), in particular the
scattering at q values of approximately 0.1 and 0.2 Å1. These
changes are consistent with the proﬁle obtained when L-Tyr is
added to wild type TmaDAH7PS and suggests that in the presence
of L-Phe or L-Tyr, all variants favour a more globular closed confor-
mation similar to that observed by the wild type TmaDAH7PS in
the presence of L-Tyr [12].
The changes to the scattering patterns collected for TmaH29A,
closely resemble the changes observed for wild type TmaDAH7PS,
suggesting the presence of L-Tyr or L-Phe (at a concentration of
1 mM) results in a similar degree of conformational change for
both proteins. However, for TmaS31G, although the changes ob-
served in the scattering proﬁles are similar, the changes are not
as pronounced as for the TmaH29A variant. The ﬂatter proﬁles sug-
gest that although the overall shape adopted by TmaS31G in the
presence of L-Tyr and L-Phe becomes more globular, this variant,
on average and including to some extent in the absence of ligand
(Fig. S2, Supplementary information), adopts a more elongated
structure. This diminished response to L-Tyr and L-Phe may indi-
cate that the regulatory domain interactions are impaired in this
variant, disfavouring the closed form. Likewise, a somewhat smal-
ler response to the presence of L-Phe and L-Tyr is seen for the
TmaH29S/S31H variant. The change in scattering proﬁle for
TmaH29S/S31H in the presence of L-Tyr or L-Phe is also less appar-
ent and displays a slight increase in change for L-Phe over L-Tyr.
The SAXS scattering proﬁles can also be analysed using OLIGO-
MER [19], which allows an estimation of the distribution of speciﬁc
species for a multicomponent mixture, in this case the open and
closed forms of TmaDAH7PS (Table 2). This analysis suggests a sim-




1 lM1) kcat/KE4Pm (s
1 lM1)
.7 ± 0.2 2.4 ± 0.1 0.9 ± 0.08
.5 ± 0.3 1.4 ± 0.1 0.58 ± 0.03
.3 ± 0.2 0.7 ± 0.1 0.43 ± 0.03
.1 ± 0.1 0.36 ± 0.01 0.50 ± 0.02
Fig. 3. Comparison of SAXS scattering proﬁles for (A) wild type TmaDAH7PS, (B) TmaS31G, (C) TmaH29A (D) and TmaH29S/S31H, in the absence of ligand (s), presence of
1 mM L-Tyr ( ) and presence of 1 mM L-Phe ( ).
Table 2
OLIGOMER [19] analysis of SAXS data.
Enzyme Ligand Opena (%) Closeda (%)
WT None 58 42
WT L-Tyr 18 82
WT L-Phe 15 86
H29A None 58 42
H29A L-Tyr 9 91
H29A LL-Phe 21 79
S31G None 92 8
S31G L-Tyr 45 55
S31G Phe 48 52
H29S/S31H None 68 32
H29S/S31H L-Tyr 30 70
H29S/S31H L-Phe 19 81
a The calculation of the approximate distribution of species assuming an equi-
librium between two species: the open tetramer (PDB code 1RZM) and closed
tetramer (PDB code 3PG9) of TmaDAH7PS. All the data was analysed by direct
capillary analysis at a concentration of 2.5 mg/ml (Table S1, Supplementary mate-
rial). The calculated species distribution differs from data collected following in line
size exclusion chromatography [12].
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the open form in solution. The conformational distribution of this
protein between closed and open forms when L-Tyr or L-Phe are
present only slightly favours the closed form for this variant, in
contrast to the wild type protein and the TmaH29A and
TmaH29S/S31H variants.
3.3. Substitutions of Ser31 and His29 give rise to changes in the
inhibitory response to L-Tyr and L-Phe
The sensitivity of the catalytic activities of each variant were
analysed using increasing concentrations of L-Tyr or L-Phe(Fig. 4). Notably, replacement of Ser31, either by substitution to
Gly or in the double variant TmaH29S/S31H, results in a signiﬁcant
loss of inhibitor potency and renders the enzyme unable to distin-
guish appreciably between L-Tyr and L-Phe. Indeed, the double mu-
tant was found to be slightly more sensitive to L-Phe than L-Tyr at
higher inhibitor concentrations.
In contrast, TmaH29A demonstrates a similar response to L-Tyr
as does the wild type enzyme. Interestingly, L-Phe is a more potent
inhibitor of TmaH29A than it is of the wild type enzyme, revealing
that the His29, while not required to support the inhibitory re-
sponse to L-Tyr, plays an important role in ligand selectivity.
4. Discussion
Allosteric regulation of TmaDAH7PS is conferred by a discrete
ACT domain [11,12]. The ACT domain is a small molecule ligand-
binding domain with a regulatory function, and its prevalence
throughout all three domains of life has led to the suggestion that
acquisition of this domain occurred early in evolution [15,20]. Typ-
ically, the ACT domain is found combined with other protein scaf-
folds and associations of multiple ACT domains form dimeric and
trimeric conformations where ligands are found to bind between
the ACT domain interfaces [15,21–23]. ACT domains bind to a di-
verse range of ligands and accordingly there is considerable inter-
est in understanding the molecular level determinants for ligand
selectivity. Despite the structural similarity of the ACT domains,
the low sequence identity of these domains provides little clue as
to the residues that may be important for deﬁning ligand
speciﬁcity.
Wild type TmaDAH7PS shows sensitivity for L-Tyr, implying
that levels of L-Tyr within this organism are appropriate to report
on the cellular requirements for DAH7PS activity and to control
Fig. 4. Comparison of TmaH29A ( ), TmaS31G ( ), Tma H29S/S31H ( ), and wild type TmaDAH7PS (j) response to increasing concentrations of (A) L-Tyr and (B) L-Phe. Error
bars represent the standard deviation.
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particularly notable, as other organisms have more complex strat-
egies for modulating DAH7PS activity in response to cellular levels
of aromatic amino acids, by the use of isozymes or by having a sin-
gle enzyme responsive to more than one ligand [5,7,24]. In addi-
tion to variable ligand speciﬁcity, DAH7PS enzymes from
different organisms show diverse molecular mechanisms for the
control of catalytic activity, and the corresponding regulatory
machinery appended to the core catalytic barrel structure is also
multifarious. Many DAH7PS enzymes, including the DAH7PSs from
M. tuberculosis, E. coli, N. meningitidis and S. cerevisiae have a
pre-formed ligand binding cavity and undergo relatively subtle
structural changes on ligand binding [2,3,5–7,9]. However, for
TmaDAH7PS the binding site for L-Tyr is only present when the
N-terminal ACT domains interact providing a ligand binding site
associated with the formation inter-subunit contacts. The linker
connecting the catalytic and regulatory domains is ﬂexible and it
appears likely that inhibition by L-Tyr results from trapping the
closed, inactive conformation by ligand binding [12]. This confor-
mation equilibrium between active and inactive forms has been
predicted for a number of other allosteric systems [25,26].
The three variants of TmaDAH7PS were expressed and shown to
be efﬁcient functional catalysts. All three proteins demonstrated
reduced catalytic efﬁciency yet higher Km values. It is interesting
to note that the truncated TmaDAH7PS lacking the ACT domain
shows a similar trend in kinetic properties [12]. Substitutions that
diminish regulatory domain contacts may alter the population dis-
tribution of the inhibitor-free forms of the enzyme, and the kinetic
parameters may be indicative of this. In addition the SAXS analysis
particularly for the TmaS31G variant is consistent with an on aver-
age, more open form of the enzyme.
Although the TmaDAH7PS is the only structurally characterised
ACT domain containing DAH7PS, sequence analysis indicates that a
range of DAH7PS proteins also have this domain incorporated at
their N terminus. Moreover, the structure of the enzyme bound
to L-Tyr, has allowed the identiﬁcation of the residues that are
likely to determine selectivity for Tyr as the allosteric inhibitor. A
search using the ﬁrst 80 amino acids of TmaDAH7PS, which com-
prise the ACT domain and the ﬂexible linker that connects this do-
main to the catalytic barrel, reveals that over 850 DAH7PS
sequences share this domain and likely possess a similar mecha-
nism of allostery (for a partial sequence alignment see Fig. S3, Sup-
plementary information). While the 29His-X-Ser31 (where X is Val,
Leu or Ile) is by far the most common motif in this region of theprotein, some variations are observed. Of note is the observation
that position 29 can also accommodate Met and the polar residues
Asn, or Asp and Glu is intermittently observed in combination with
Lys at position 30 whereas Ile or Val are also frequently observed at
position 31.
In the L-Tyr-bound structure of TmaDAH7PS, Ser31 forms a
hydrogen-bond with the hydroxyl moiety of the bound L-Tyr ligand
and to His29 from the paired regulatory domain which may ensure
correct positioning of Ser31 to bind L-Tyr and the optimal construc-
tion of the ligand-binding pocket. The diminished inhibition of the
variants in which Ser31 is substituted and the SAXS proﬁles clearly
show that this residue plays a signiﬁcant role in L-Tyr inhibition of
TmaDAH7PS, and in altering the position of the conformational
equilibrium of the protein in the presence of inhibitor. The loss
of sensitivity to L-Tyr seen for the TmaS31G variant appears to be
associated predominantly with the loss of the hydrogen-bond to
the hydroxyl side chain of Ser31, rather than the loss of the inter-
molecular hydrogen-bond between His29 and Ser31, as the Tma-
H29A variant is similarly inhibited by L-Tyr as the wild type
enzyme. However, although the response to L-Tyr is largely unaf-
fected by the loss of the imidazole side-chain in the TmaH29A mu-
tant, the selection for L-Tyr over L-Phe is diminished. This change
may be a direct result of the ﬂexibility afforded by the absence of
the hydrogen bond between Ser31 and His29 and associated
improvement in the accommodation of L-Phe in the allosteric
inhibitor-binding site (Fig. S4, Supplementary information).
The loss of hydrogen-bonding interactions by the simultaneous
exchange of His 29 and Ser31 severely affects selectivity and sen-
sitivity to inhibition by L-Tyr. Assuming L-Tyr binds in the same
location as for the L-Tyr-bound TmaDAH7PS, analysis of the possi-
ble rotamers accessible in these exchanged positions suggests
there is no arrangement that would permit hydrogen-bonding
interactions between the L-Tyr hydroxyl moiety and His31 and
Ser29 (Fig. S5, Supplementary information). However, an extended
hydrogen bond between His31 and the main chain of Ser29 is fea-
sible. Nevertheless, inhibition results for TmaS31G and TmaH29S/
S31H suggest the hydrogen bond, speciﬁcally to the L-Tyr hydroxyl
group, is compromised in line with the similar abilities of L-Tyr and
L-Phe to inhibit these variants. These results are further reﬂected
by the SAXS proﬁles obtained for these two variants, in the absence
and presence of L-Tyr and L-Phe, which show a decreased response
to inhibitor-induced conformational change.
Understanding the role of Ser31 and His 29 in TmaDAH7PS al-
lows the inhibitor selectivity of other ACT domain containing type
3068 P.J. Cross, E.J. Parker / FEBS Letters 587 (2013) 3063–3068Ib DAH7PSs to be deduced by sequence comparisons. Notably,
29His-X-Ser31 is a recurring motif at this position in the ACT do-
main containing DAH7PSs, suggesting that inhibition by Tyr is a
common strategy for organisms with a DAH7PS fused to this regu-
latory domain (Fig. S3, Supplementary information). Orthologues
that do not share this motif, have Ile or Val in place of Ser31, sug-
gesting a subset of these proteins show different inhibitor selectiv-
ity. That this inhibitor selectivity can be altered by simple
substitution of either one or two residues of the regulatory domain
reveals that relatively facile adaption is required to alter the re-
sponse to a different end product of the pathway.
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